Print ISSN:-2582-6301

Online ISSN:-2582-628X

Article History

Received : 29-12-2021

Accepted : 19-01-2022



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 443

PDF Downloaded: 385


Lipoprotein (a) levels in newly diagnosed treatment naive type 2 diabetics & it’s correlation with glycemic & lipid parameters


Full Text PDF


Original Article

Author Details : Avijit Saha*

Volume : 4, Issue : 4, Year : 2021

Article Page : 171-175

https://doi.org/10.18231/j.ijnmhs.2021.030



Suggest article by email

Get Permission

Abstract

Background and Aims: Type 2 diabetes mellitus (T2DM) has a high morbidity and mortality mainly due to cardiovascular diseases. Besides traditional risk factors, Lp(a) has recently been emerged as an independent risk factor. This study aimed to evaluate the incidences of elevated Lp(a) levels in newly diagnosed T2DM Pts and to find the pattern of lipid profile abnormalities associated with elevated Lp(a) group of pts & it’s correlation with glycemic & lipid parameters.
Materials and Methods: This present study was conducted in newly diagnosed treatment naïve type 2 diabetic patients. After obtaining informed consent, all participants completed a survey to obtain anthropometric & clinical information. Venous blood samples were drawn for fasting plasma glucose, postprandial glucose, HbA1c,lipid profile & Lp(a) measurements.
Results: A total 70 newly diagnosed type 2 diabetic pts & 50 healthy controls were studied. The mean Lp(a)level measured among diabetics was 34.17 ±33.25 mg/dl. The mean concentration of Lp(a) in diabetics was significantly higher than control group(<0> Conclusion: Our study demonstrated Type 2 diabetics had statistically significant higher levels of Lp(a). The residual lipid risk is probably contributed by this molecule So, every diabetic should have checked their level at least once in a lifetime to predict CV risk.


Keywords: Type2 Diabetes mellitus, Lipoprotein- a Lp (a).



How to cite : Saha A, Lipoprotein (a) levels in newly diagnosed treatment naive type 2 diabetics & it’s correlation with glycemic & lipid parameters. J Nutr Metab Health Sci 2021;4(4):171-175


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.